Critical appraisal of trastuzumab in treatment of advanced stomach cancerThe 20th anniversary of interleukin-2 therapy: bimodal role explaining longstanding random induction of complete clinical responsesNedaplatin: a cisplatin derivative in cancer chemotherapyRole of denileukin diftitox in the treatment of persistent or recurrent cutaneous T-cell lymphomaCapecitabine in the management of colorectal cancerAdvanced soft-tissue sarcoma and treatment options: critical appraisal of trabectedinTreatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancerFosaprepitant dimeglumine for the management of chemotherapy-induced nausea and vomiting: patient selection and perspectivesMultidisciplinary management for esophageal and gastric cancerNovel approaches to target HER2-positive breast cancer: trastuzumab emtansineDronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemeticsNeoadjuvant therapy for early-stage breast cancer: the clinical utility of pertuzumabClinical utility of RapidArc™ radiotherapy technology.Rationale and development of image-guided intensity-modulated radiotherapy post-prostatectomy: the present standard of care?Critical appraisal of rituximab in the maintenance treatment of advanced follicular lymphomaTargeting autophagy in cancer management - strategies and developmentsPotential of epigenetic therapies in the management of solid tumorsThe treatment landscape in thyroid cancer: a focus on cabozantinibProgress toward overcoming hypoxia-induced resistance to solid tumor therapyReview of advanced catheter technologies in radiation oncology brachytherapy proceduresNew and emerging factors in tumorigenesis: an overviewClinical management of grade III oligodendrogliomaPersonalized treatment for advanced colorectal cancer: KRAS and beyondPrognostic stratification of colorectal cancer patients: current perspectivesFertility preservation during cancer treatment: clinical guidelinesNew modalities of cancer treatment for NSCLC: focus on immunotherapyMalignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methodsAbiraterone in the treatment of metastatic castration-resistant prostate cancerA comprehensive review of nongenetic prognostic and predictive factors influencing the heterogeneity of outcomes in advanced non-small-cell lung cancerManagement of patients with hormone receptor-positive breast cancer with visceral disease: challenges and treatment optionsTreatment of metastatic colorectal cancer: focus on panitumumabTargeting CD19 in B-cell lymphoma: emerging role of SAR3419Evaluating the safety and efficacy of axitinib in the treatment of advanced renal cell carcinomaUpdate on benefit of immunotherapy and targeted therapy in melanoma: the changing landscape.Atypical teratoid/rhabdoid tumors: challenges and search for solutionsRole of tolvaptan in the management of hyponatremia in patients with lung and other cancers: current data and future perspectivesAfatinib for the treatment of metastatic non-small cell lung cancerOccupational exposure to wood dust and formaldehyde and risk of nasal, nasopharyngeal, and lung cancer among Finnish menConsidering renal risk while managing cancer.Association of fatigue and depression with circulating levels of proinflammatory cytokines and epidermal growth factor receptor ligands: a correlative study of a placebo-controlled fatigue trial.
P1433
Q24604411-07F7773A-FC5A-458C-A6CD-A2ED253B0B01Q24616434-9F31DCD6-9C47-4658-B079-408F89F36F07Q24623561-DCD51407-B2CF-443C-861E-DC73E9156DF7Q24626963-D4637425-9481-4D16-B7DA-3A5EF97A4C3FQ24633039-FC080DA8-08C1-4B94-8697-221019DBD366Q26738346-1E123DBB-4DE3-4DC3-B3CE-85072FE408F6Q26741153-52727BD8-3B68-4C9E-8384-02C4A815C013Q26744323-34C48BE5-0897-40E9-8BF5-E7857FDBEE3EQ26746207-E5D6848D-7229-4B3B-B7BB-6C79384C5D5FQ26747729-6856B294-071E-4C6B-9AC3-DAE2F7D52A2BQ26747733-9F43D7AF-13E5-4A93-8834-EDE061B55F17Q26764879-5C17AC6A-4FCB-45F6-A70B-1769F245FF5BQ26773193-716AEAC5-E9C0-416C-A988-7FDE7283F368Q26774847-2D07D188-4735-4DB2-9205-C233C012E427Q26775837-F898742B-3E15-4255-BE8A-A605DDA5EB74Q26782468-90056094-3B64-45A6-9654-6D8125B690A0Q26783134-96449F19-E63B-490C-82BC-78E38D73DBA9Q26796404-73F11A1B-5789-4DCE-B2E3-80EB4D78278CQ26796405-B948F4A0-0DBF-4DC1-820E-10F6863CA72FQ26800257-A1CF2A34-4D9D-4483-AB44-7AE21DD945D4Q26801253-43DA4AB0-25FC-4FE4-B59D-6C4F9C92E6E2Q26801254-9D1259EA-FB0F-4CD1-9B76-CD62B11437FEQ26822817-A50E7F5D-02D0-4CFD-9CF3-FD66295F364CQ26823543-3D66D96B-9535-42A2-B767-1F258FF4A6D7Q26823947-94185C9A-6637-48CA-B2A0-2B90BCE5AF9BQ26829161-DCE32F88-81D2-4792-955D-335AA3EFBBB4Q26853516-B7B8BA4A-36ED-4D03-870A-891B8609FE51Q26853635-21CF55D4-A089-4CC9-9C17-0940233DA7E4Q26865662-C1D93BF7-AEF1-46DC-A281-1F3784AC6BEAQ26995549-418F3D58-E99A-4CAE-8BB4-BA319E9EB9B3Q27022954-E3FD21B5-1726-4924-8327-114E0B2818DFQ27027562-93BA05ED-94A4-420C-A5C2-023CCA45617FQ27028048-9014F566-3A1D-4416-8F64-6457206637D3Q27691824-2DE927CB-E6CC-4D2B-87F5-F6FC431BA3E6Q28066905-27730A14-FC5E-4F4B-97A3-3E4FFA1CDDF4Q28072768-2C00148E-E18B-4278-9BAB-A519B5D812F1Q28082181-8D8E4EAF-FFA8-4D85-BAF8-9F3F4894510FQ28387590-A571E5A5-DF7A-43D8-8931-C818104069D9Q30234338-0390654F-C82C-4877-B56B-22A1E836FEB7Q30354107-81D5009E-4827-4263-BCC7-30803F174404
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
vědecký časopis
@cs
wetenschappelijk tijdschrift van Dove Medical Press
@nl
wissenschaftliche Fachzeitschrift
@de
مجلة
@ar
वैज्ञानिक पत्रिका
@hi
name
Cancer Management and Research
@ast
Cancer Management and Research
@en
Cancer Management and Research
@es
Cancer Management and Research
@it
Cancer Management and Research
@nl
type
label
Cancer Management and Research
@ast
Cancer Management and Research
@en
Cancer Management and Research
@es
Cancer Management and Research
@it
Cancer Management and Research
@nl
prefLabel
Cancer Management and Research
@ast
Cancer Management and Research
@en
Cancer Management and Research
@es
Cancer Management and Research
@it
Cancer Management and Research
@nl
P31
P243
P3181
P1055
P1058
P1156
19700175043
P1277
P1476
Cancer Management and Research
@en
P236
P243
P3181
P407
P5115
P571
2009-01-01T00:00:00Z